Drug Coated Balloon Angioplasty in Failing AV Fistulas: A Randomized Controlled Trial.
BACKGROUND Restenosis remains a problem in hemodialysis access interventions. Paclitaxel-coated balloons have shown promise in reducing access-related restenosis in small trials.
S. Trerotola +3 more
semanticscholar +1 more source
Treatment of atherosclerotic renovascular hypertension: review of observational studies and a meta-analysis of randomized clinical trials. [PDF]
open9Atherosclerotic renal artery stenosis can cause ischaemic nephropathy and arterial hypertension. We herein review the observational and randomized clinical trials (RCTs) comparing medical and endovascular treatment for control of hypertension and ...
Caielli, P +8 more
core +1 more source
PURPOSEIt is not easy to determine whether balloon angioplasty or stenting should be performed in patients with portal vein stenosis after liver transplantation.
Kyeong Sik Kim +5 more
doaj +1 more source
Isolated Gastric Varix Bleeding Caused by Splenic Vein Obstruction: Two Case Reports
Isolated left-sided portal hypertension is a rare clinical syndrome caused by splenic veno-occlusive disease. Splenic vein thrombosis and extrinsic compression causes proximal splenic vein hypertension, and the splenic blood flows into the superior ...
Juyoung Pak +5 more
doaj +1 more source
Macromolecular approaches to prevent thrombosis and intimal hyperplasia following percutaneous coronary intervention. [PDF]
Cardiovascular disease remains one of the largest contributors to death worldwide. Improvements in cardiovascular technology leading to the current generation of drug-eluting stents, bioresorbable stents, and drug-eluting balloons, coupled with advances ...
Panitch, Alyssa, Scott, Rebecca A
core +2 more sources
Carotid Artery Stent Continued Expansion Days After Deployment, Without Post Stent Deployment Angioplasty. [PDF]
This is a carotid artery stent (CAS) case report, which avoids post-stent deployment angioplasty (Post-SDA), with duplex confirmed continued stent expansion at 1, 3 and 30-day post deployment.
Arhuidese, Isibor +3 more
core +3 more sources
Oxidant and antioxidant status in patients undergoing percutaneous coronary interventions
Background: Coronary artery disease (CAD) is the major disease leading to cause mortality and morbidity. The imbalance between the generation of reactive oxygen species (ROS) and the intrinsic antioxidant defense system leading to the oxidative stress ...
Vonteru Lakshmi Asha Latha
doaj +1 more source
Infarct size and left ventricular remodelling after preventive percutaneous coronary intervention [PDF]
Objective: We hypothesised that, compared with culprit-only primary percutaneous coronary intervention (PCI), additional preventive PCI in selected patients with ST-elevation myocardial infarction with multivessel disease would not be associated with ...
Berry, Colin +13 more
core +1 more source
Time to Treatment Delay and Clinical Indicators in Patients with ST-Segment Elevation Myocardial Infarction: A Descriptive Cross-sectional Study [PDF]
Introduction: ST-segment elevation myocardial infarction (STEMI) continues to be a significant global health issue, necessitating ongoing monitoring of care processes to enhance quality.
Mahsa Motadayen +3 more
doaj +1 more source
The IkB kinase inhibitor nuclear factor-kB essential modulator–binding domain peptide for inhibition of balloon injury-induced neointimal formation [PDF]
Objective—The activation of nuclear factor-kB (NF-kB) is a crucial step in the arterial wall’s response to injury. The identification and characterization of the NF-kB essential modulator– binding domain (NBD) peptide, which can block the activation of
Carnuccio, R. +12 more
core +1 more source

